Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Publications 2016

Peer reviewed publications by fellows and researchers 2016

  • Smith JG, Felix JF, Morrison AC, Kalogeropoulos A, Trompet S, Wilk J, Gidlöf O, Wang X, Morley M, Shan X, Bis JC, Wang YA, Sjögren M, Ngwa J, Brandimarto J, Stott DJ, Aguilar D, Rice KM, Sesso HD, Dermissie S, Buckley BM, Taylor K, Ford I, Sotoodehnia N, van der Harst P, Stricker BHC, Kritchevsky SB, Liu Y, Gaziano JM, Hofman A, Moravec CS, Uitterlinden AG, Kellis M, Margulies KB, Olde B, Psaty BM, Cupples A, Jukema JW, Djousse L, Franco OH, Boerwinkle E, Newton-Cheh C, Butler J, Vasan RS, Cappola TP, Smith NL. (2016) Discovery of genetic variation on chromosome 5q22 associated with mortality in heart failure. PLoS Genet 12(5): e1006034. doi: 10.1371/journal.pgen.1006034.
     
  • Wu C, Arora P, Agha O, Hurst L, Allen K, Hu D, Jiramongkolchai P, Smith JG, Melander O, Domian I, Wang TJ, Bloch KD, Buys ES, Bloch DB, Newton-Cheh C. Multiple microRNAs target the mRNA encoding atrial natriuretic peptide. (2016) Mol Cell Biol 36(14): 1977-87. doi: 10.1128/MCB.01114-15.
     
  • Berntsson J, Östling G, Persson M, Smith JG, Hedblad B, Engström G. Orosomucoid, carotid plaque and incidence of stroke. (2016) Stroke 47(7): 1858-63. doi: 10.1161/STROKEAHA.116.013374.
     
  • Mokhtari A, Lindahl B, Smith JG, Holzmann MJ, Khoshnood A, Ekelund U. Accuracy of initial high sensitivity cardiac Troponin T at presentation combined with history and ECG for ruling out major adverse cardiac events. (2016) Ann Emerg Med 68(6): 649-58. doi: 10.1016/j.annemergmed.2016.06.008.
     
  • Lindgren M, Smith JG, Li X, Sundquist J, Sundquist K, Zöller B. Sibling risk of hospitalization for heart failure: a nationwide study. (2016) Int J Cardiol 223: 379-84. doi: 10.1016/j.ijcard.2016.08.067
     
  • Padel T, Özen I, Boix J, Barbariga M, Gaceb A, Roth M and Paul G. (2016) Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson’s disease. Neurobiology of Disease. 94:95-105. doi: 10.1016/j.nbd.2016.06.002
     
  • Loane C, Politis M, Kefalopoulou Z, Valle-Guzman N, Paul G,  Widner H, Foltynie T, Barker R, Piccini P. (2016) Aberrant nigro-striatal diffusion in Parkinson’s disease: a longitudinal DTI study. Mov Disord. 31(7):1020-6. doi: 10.1002/mds.26606
     
Page Manager:

Wallenberg Centre for Molecular Medicine
Klinikgatan 32
221 84 Lund
Phone: 046-222 00 00 (switchboard)